ICRA assigns ‘A1+’ rating to Lupin’s short-term credit facilities

01 Apr 2015 Evaluate

Credit rating agency, ICRA has assigned ‘A1+’ rating to Lupin’s short-term credit facilities of Rs 1310 crore. The rating agency has also assigned ‘AA+’ rating to the company’s long-term credit facilities worth Rs 190 crore. Moreover, the rating agency has assigned ‘AA+’ rating to the company’s Non-Convertible Debenture (NCD) programme worth Rs 100 crore.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×